I got a reply from LCT today, which Professor Elliot heads up. Will be interested to see what happens next. I feel like I’m a very minute part of a very exciting scientific break-through and it will be interesting even just to observe this moving forward.

Thank you for your email and interest in LCT.

We are delighted to be able to get clinical trials underway in New Zealand, the place where the DiabeCell® concept was initially conceived by Professor Bob Elliott.

Dr John Baker, diabetes consultant at Middlemore is conducting this trial for LCT and is responsible for selecting participants with type 1 diabetes.  We shall forward your details to Dr Baker.

If you are not already registered, LCT shall add your name to our database of enquiries regarding clinical trials.  This will ensure that you receive regular, up-to-date newsletters and ongoing information with regard to LCT’s progress towards human clinical trials and, eventually, product availability for Type 1 Diabetes.

Thank you for your support.